IperionX Completes Commissioning of Titanium Manufacturing Campus and Expands Production Capacity

Reuters
01/30
IperionX Completes Commissioning of Titanium Manufacturing Campus and Expands Production Capacity

IperionX Ltd. announced the completion of commissioning for equipment and systems related to titanium powder production and component manufacturing at its Titanium Manufacturing Campus in Virginia. The company reported that advanced manufacturing capabilities have expanded, with both a 100-ton uniaxial press and a dry bag cold isostatic press now operational. A new 300-ton hydraulic press is set to begin commissioning. As of December 31, 2025, IperionX held a cash balance of US$65.8 million. The company has received a total of US$59.8 million in U.S. Government grants through the Department of Defense’s DPA Title III and IBAS/ICAM programs, with all funds fully obligated and US$13.3 million reimbursed to date. A remaining balance of US$46.5 million is available for future reimbursement to support operations and expansion. IperionX reported that pilot-scale work on a new continuous titanium production process is underway, with completion targeted in 2026. The company is also advancing development of a new facility in Halifax County, Virginia, to host next-generation production technologies. The estimated cost for expansion is approximately US$75 million, with the majority of capital secured via the IBAS program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IperionX Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-002866), on January 30, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10